A Game Changer In Healthcare
Transform Medicine - Scenario
Lisa, the Chief Medical Officer of the Best Pharmaceutical and Biotech has a formidable challenge in front of her. Best Pharma has been on a downward curve with revenues and profits declining, aging products, stiff competition, drying pipelines and a string of failed product launches. The Executive Committee has charged her with the task to rethink and redesign the drug development model of the company.
Lisa stepped back and took a fresh look at the Best Pharma and the industry as a whole, and came to some startling conclusions:
Lisa’s insights into the Best Pharma and the industry as a whole are right on. Issues she outlined are at the core to what ails the Best Pharma and the industry as a whole.
A holistic view of the patient and therefore the outcomes of therapies would dramatically shift the focus of the industry from expensive and improbable one-size-fits-all blockbuster therapies, to targeted, speedier and significantly more effective solutions delivered at much lower cost to the patients.
PHI (Φ) Difference
PHI (Φ) as a SINGLE measure of health and vitality for the Whole Person representing multiple factors and dimensions, is a powerful tool for competitive advantage for the pharmaceutical and biotech companies, a potential game changer in drug development, measurement of efficacy of drugs and therapies, and a platform to advance precision medicine:
Reinvent Drug Development Model and Process
Increase regulatory successes
Gain market share and credibility
Change the game with the Whole Person efficacy measurement
Accelerate Precision Medicine
© 2013 valueideas.
All rights reserved.